Gaurav Aggarwal

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Menlo Park, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Gaurav Aggarwal
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Gaurav Aggarwal

Form 4 holding Director

Unicycive Therapeutics, Inc.

Security class
Series A-2 Prime Preferred Stock
Shares / value
0
Estimated value
$0
Report date
25 Aug 2025
Price
$1000.00
Ownership
By Vivo Opportunity Fund Holdings L.P.
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

GERON CORP

Security class
Stock Option (right to buy)
Shares / value
180,000
Estimated value
Report date
21 May 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Sierra Oncology, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
01 Jul 2022
Price
$55.00
Ownership
By: Vivo Opportunity Fund Holdings, L.P.
Form 4 holding Director

Sierra Oncology, Inc.

Security class
Series A Warrant
Shares / value
0
Estimated value
Report date
01 Jul 2022
Price
Ownership
By: Vivo Opportunity Fund Holdings, L.P.
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Sierra Oncology, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
01 Jul 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Gaurav Aggarwal

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .